You are here

Article info

Article menu
Download PDFPDF
Multiple sclerosis
Research paper
MRI characteristics of early PML-IRIS after natalizumab treatment in patients with MS

Authors

  • Mike P Wattjes MS Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands Department of Radiology and Nuclear Medicine, VU University Medical Center, Amsterdam, The Netherlands PubMed articlesGoogle scholar articles
  • Martijn T Wijburg MS Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands Department of Radiology and Nuclear Medicine, VU University Medical Center, Amsterdam, The Netherlands Department of Neurology, VU University Medical Center, Amsterdam, The Netherlands PubMed articlesGoogle scholar articles
  • Anke Vennegoor MS Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands Department of Neurology, VU University Medical Center, Amsterdam, The Netherlands PubMed articlesGoogle scholar articles
  • Birgit I Witte Department of Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, The Netherlands PubMed articlesGoogle scholar articles
  • Marlieke de Vos MS Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands Department of Radiology and Nuclear Medicine, VU University Medical Center, Amsterdam, The Netherlands PubMed articlesGoogle scholar articles
  • Nancy D Richert Multiple Sclerosis Clinical Development Group, Biogen, Cambridge, Massachusetts, USA PubMed articlesGoogle scholar articles
  • Bernard M J Uitdehaag MS Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands Department of Neurology, VU University Medical Center, Amsterdam, The Netherlands PubMed articlesGoogle scholar articles
  • Frederik Barkhof MS Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands Department of Radiology and Nuclear Medicine, VU University Medical Center, Amsterdam, The Netherlands PubMed articlesGoogle scholar articles
  • Joep Killestein MS Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands Department of Neurology, VU University Medical Center, Amsterdam, The Netherlands PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Mike P Wattjes, Department of Radiology and Nuclear Medicine, MS Center Amsterdam, VU University Medical Center, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands; m.wattjes{at}vumc.nl
View Full Text

Citation

Wattjes MP, Wijburg MT, Vennegoor A on behalf of the Dutch-Belgian Natalizumab-associated PML study group, et al
MRI characteristics of early PML-IRIS after natalizumab treatment in patients with MS
Journal of Neurology, Neurosurgery & Psychiatry 2016;87:879-884.

Publication history

  • Received May 30, 2015
  • Revised July 20, 2015
  • Accepted August 26, 2015
  • First published September 14, 2015.
Online issue publication 
July 14, 2016

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/